Janghorban, Mahnaz <br/><br/>
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jun 2014 
 - 9157-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1317630111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autoantigens--biosynthesis<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>DNA-Binding Proteins<br/>Drug Delivery Systems<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Knockdown Techniques<br/>Histone Chaperones--biosynthesis<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Membrane Proteins--biosynthesis<br/>Protein Phosphatase 2--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Transcription Factors--biosynthesis